KARE: Kidney Awareness Registry and Education

Sponsor
University of California, San Francisco (Other)
Overall Status
Completed
CT.gov ID
NCT01530958
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)
375
2
4
93
187.5
2

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the feasibility and acceptability of two different interventions aimed at improving health outcomes among patients with chronic kidney disease (CKD), who are at high risk of CKD progression. Specifically, this study will examine how best to implement a provider-level intervention (access to a CKD-registry) and a patient-oriented intervention (automated telephone self-management (ATSM) + health coach) on patient health outcomes, with a 2x2 factorial design.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CKD Registry
  • Behavioral: ATSM + Health Coach
  • Behavioral: Usual care
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
375 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
The Kidney Awareness Registry and Education Study
Actual Study Start Date :
Apr 1, 2013
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: ATSM + Health Coach and CKD Registry

Behavioral: CKD Registry
Primary care providers (PCPs) will have access to a Chronic Kidney Disease (CKD) registry for patient care. The registry will: identify patients with CKD notify PCPs of a patients' CKD status provide PCP outreach with NKDEP guidelines and patient educational materials

Behavioral: ATSM + Health Coach
Patients with CKD will participate in an Automated Telephone Self Management (ATSM) program, which blends automated phone calls with live targeted call-backs from a health coach. Patients will receive bi-weekly automated calls for 52 weeks in their native language, consisting of pre-recorded queries pertaining to CKD management, preventive services, and lifestyle changes. Patients will interact with the system using a touch-tone keypad; Out-of-range values or invalid responses will prompt a live call-back within 24-48 hours by a health coach.

Active Comparator: CKD Registry

Behavioral: CKD Registry
Primary care providers (PCPs) will have access to a Chronic Kidney Disease (CKD) registry for patient care. The registry will: identify patients with CKD notify PCPs of a patients' CKD status provide PCP outreach with NKDEP guidelines and patient educational materials

Active Comparator: ATSM + Health Coach

Behavioral: ATSM + Health Coach
Patients with CKD will participate in an Automated Telephone Self Management (ATSM) program, which blends automated phone calls with live targeted call-backs from a health coach. Patients will receive bi-weekly automated calls for 52 weeks in their native language, consisting of pre-recorded queries pertaining to CKD management, preventive services, and lifestyle changes. Patients will interact with the system using a touch-tone keypad; Out-of-range values or invalid responses will prompt a live call-back within 24-48 hours by a health coach.

Placebo Comparator: Usual Care (no interventions)

Behavioral: Usual care
Primary care providers will manage their patients with CKD per usual care. Patients will receive usual care.

Outcome Measures

Primary Outcome Measures

  1. Change in blood pressure measurement at baseline and at one year follow-up [Baseline and one year follow-up]

    Blood pressure will be measured at baseline and also at the follow-up visit at one year

Secondary Outcome Measures

  1. Change in CKD awareness, functional status, and symptoms at baseline and at one year follow-up [Baseline and one year follow-up]

    CKD awareness, functional status, and symptoms will be measured at baseline and also at the follow-up visit at one year. Assessments will be made by standardized phone calls throughout the study.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients with CKD (defined as estimated Glomerular Filtration Rate < 60ml/min/1.73m2 or proteinuria consistently over 3 months) who speak English, Spanish or Cantonese and have a primary care provider
Exclusion Criteria:
  • Kidney transplant recipients; pregnant women; individuals with an eGFR <15 ml/min/1.73 m2; prevalent dementia; impaired cognition or severe mental illness; expected life expectancy <6 months; no phone access; self-reported hearing impairment; severe visual impairment preventing use of a touch-tone telephone keypad; and non-study language

Contacts and Locations

Locations

Site City State Country Postal Code
1 San Francisco Department of Public Health San Francisco California United States 94110
2 San Francisco General Hospital San Francisco California United States 94110

Sponsors and Collaborators

  • University of California, San Francisco
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

  • Principal Investigator: Neil Powe, MD, University of California, San Francisco

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01530958
Other Study ID Numbers:
  • 11-07399
  • 1R34DK093992-01
First Posted:
Feb 10, 2012
Last Update Posted:
Jan 22, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by University of California, San Francisco
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 22, 2021